Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR Fortrea Holdings Inc (K67.MU) Follow Add holdings 5.30 -0.15 (-2.75%) As of 8:00:12 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for K67.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: K67.MU View More All News Press Releases SEC Filings Fortrea Holdings Inc.'s (NASDAQ:FTRE) Intrinsic Value Is Potentially 84% Above Its Share Price Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025 Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call Fortrea Holdings Inc (FTRE) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance Fortrea to Add Erin L. Russell to Board of Directors Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research Several Insiders Invested In Fortrea Holdings Flagging Positive News Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call Fortrea downgraded to Neutral from Outperform at Baird Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors Related Tickers NGNE Neurogene Inc. 13.62 -9.86% ORIC ORIC Pharmaceuticals, Inc. 4.9182 -13.72% ADVM Adverum Biotechnologies, Inc. 3.2900 -8.36% DYN Dyne Therapeutics, Inc. 11.49 -2.87%